New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Biofrontera Inc.
BFRI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

8M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 May 2025

8M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 May 2025

0.92USD

Shape0.03 ( 2.86%)
Market Open
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-93%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

62%

Quote Panel

Shape
Updated March 27, 2025
1W 4.65 % 1M -7.72 % 3M -18.92 % 1Y -41.56 %

Key Metrics

Shape
  • Market Cap

    7.72M


  • Shares Outstanding

    8.87M


  • Share in Float

    7.33M


  • Dividende

    0


  • Earning Date

    21 May 2025


  • Price Target

    0.87


  • Average Volume

    399772


  • Beta

    0.313


  • Range

    0.651-2.43


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.biofrontera.us.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

BFRI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$43M

Shape246%

2025-Revenue

$0.77

Shape-126%

2025-EPS

$21M

Shape-220%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Benchmark

initialise

Previous: Not converted

2021-12-21

Now: Buy

Roth Capital

initialise

Previous: Not converted

2021-11-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-4.40
vs -1.60

Q2.23

arrow
arrow

N/A

-6.14
vs -8.80

Q3.23

arrow
arrow

N/A

-4.64
vs -4.60

Q4.23

arrow
arrow

N/A

-2.33
vs -2.80

Q1.24

arrow
arrow

N/A

-1.85
vs -4.40

Q2.24

arrow
arrow

N/A

-1.12
vs -6.14

Q3.24

arrow
arrow

N/A

-0.86
vs -4.64

Q4.24

arrow
arrow

N/A

-0.00
vs -2.33

Q1.25

arrow
arrow

N/A

-0.21
vs -1.85

Q2.25

arrow
arrow

N/A

-0.33
vs -1.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-10%

8.7M  vs 9.8M

Q2.23

arrow
arrow

+31%

5.8M  vs 4.5M

Q3.23

arrow
arrow

+105%

8.9M  vs 4.3M

Q4.23

arrow
arrow

+4%

10.6M  vs 10.1M

Q1.24

arrow
arrow

-10%

7.9M  vs 8.7M

Q2.24

arrow
arrow

+34%

7.8M  vs 5.8M

Q3.24

arrow
arrow

+2%

9M  vs 8.9M

Q4.24

arrow
arrow

+18%

12.6M  vs 10.6M

Q1.25

arrow
arrow

+34%

10.6M  vs 7.9M

Q2.25

arrow
arrow

+16%

9.1M  vs 7.8M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-45%

-0.45
vs -0.12

Q2.23

arrow
arrow

-137%

-1.37
vs -0.45

Q3.23

arrow
arrow

-611%

-6.11
vs -1.37

Q4.23

arrow
arrow

+74%

0.74
vs -6.11

Q1.24

arrow
arrow

+193%

1.93
vs 0.74

Q2.24

arrow
arrow

-2%

-0.02
vs 1.93

Q3.24

arrow
arrow

-103%

-1.03
vs -0.02

Q4.24

arrow
arrow

-31%

-0.31
vs -1.03

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

12

12
vs NA

NA

Q1.22

arrow
arrow

11

11
vs 12

-8%

Q2.22

arrow
arrow

13

13
vs 11

18%

Q3.22

arrow
arrow

13

13
vs 13

NA

Q4.22

arrow
arrow

14

14
vs 13

8%

Q1.23

arrow
arrow

15

15
vs 14

7%

Q2.23

arrow
arrow

11

11
vs 15

-27%

Q3.23

arrow
arrow

1

1
vs 11

-91%

Earnings Growth

Latest News